Can You Take Cialis (Tadalafil) with Levothyroxine?

Interaction Severity: What the Evidence Shows

This combination carries a low interaction risk. Neither the FDA-approved tadalafil label nor the FDA-approved levothyroxine label lists the other drug as a contraindication or precaution. Major drug interaction databases (Lexicomp, Micromedex, Clinical Pharmacology) classify tadalafil plus levothyroxine as having no established interaction.

Why the risk is minimal: tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor metabolized by CYP3A4 in the liver, while levothyroxine is a synthetic thyroid hormone cleared through hepatic glucuronidation, sulfation, and peripheral deiodination. These pathways do not overlap. Neither drug meaningfully inhibits or induces the other's clearance mechanism.

The absence of interaction does not mean prescribers should ignore co-administration altogether. Levothyroxine has a narrow therapeutic index, and its oral bioavailability is sensitive to stomach pH, food, and co-ingested substances. Those absorption vulnerabilities are the only practical concern here.

Why Levothyroxine Absorption Matters More Than CYP Overlap

Levothyroxine absorption occurs primarily in the jejunum and upper ileum, with bioavailability ranging from 40% to 80% depending on the formulation and the gastric environment. The American Thyroid Association (ATA) guidelines recommend taking levothyroxine on an empty stomach, at least 30 to 60 minutes before breakfast, to maximize absorption.

Substances known to impair levothyroxine absorption include calcium supplements, iron salts, proton pump inhibitors, and aluminum-containing antacids. A 2017 systematic review in Thyroid catalogued over a dozen drugs and foods that reduce levothyroxine bioavailability through pH alteration or chelation. Tadalafil was not among them. The PDE5 inhibitor class does not alter gastric pH or bind divalent cations.

Patients who take tadalafil on demand (10 mg or 20 mg before sexual activity) often take it with or after an evening meal. If they also shift their levothyroxine dose to the evening, food proximity could still reduce T4 absorption. A 2010 study in the Archives of Internal Medicine showed bedtime levothyroxine dosing can work, but only when the patient fasts for 2 to 3 hours before the dose. The safest practice: keep levothyroxine in the morning on an empty stomach and take tadalafil whenever it is needed, without rearranging the thyroid dose.

Tadalafil Pharmacokinetics: CYP3A4 and What Matters

Tadalafil's pharmacokinetic profile is well characterized. It reaches peak plasma concentrations in roughly 2 hours, carries a half-life of 17.5 hours, and is metabolized predominantly by CYP3A4 to a catechol metabolite that is then glucuronidated. A minor contribution comes from CYP2C9.

Drugs that powerfully inhibit CYP3A4 (ketoconazole, ritonavir, clarithromycin) increase tadalafil exposure. In a PK study, ketoconazole 400 mg daily raised tadalafil AUC by 312%. Levothyroxine has no inhibitory or inductive effect on CYP3A4, CYP2C9, or any other cytochrome P450 enzyme. It is simply not a player in the CYP system.

P-glycoprotein (P-gp) transport is sometimes raised as a theoretical concern for PDE5 inhibitors. Tadalafil does have some P-gp substrate activity in vitro. Levothyroxine is not a known P-gp inhibitor or inducer. No published pharmacokinetic data suggest a P-gp-mediated interaction between these two drugs.

The Hypothyroidism and Erectile Dysfunction Connection

The clinical reason these drugs are co-prescribed is straightforward: hypothyroidism and erectile dysfunction overlap frequently. A 2008 study published in the Journal of Clinical Endocrinology & Metabolism found that 79% of men with hypothyroidism reported some degree of erectile dysfunction, and 64% reported reduced libido. After thyroid hormone normalization, ED improved significantly in most subjects without any ED-specific medication.

Thyroid hormones modulate nitric oxide synthase expression in cavernosal smooth muscle. When T3 and T4 levels drop, nitric oxide availability falls, PDE5 expression may shift, and the erectile response weakens. A 2005 paper in International Journal of Impotence Research documented reduced cavernosal relaxation in hypothyroid animal models, partially reversible with thyroid replacement.

This means treating the underlying thyroid disorder is the first step. Some men find that once their TSH reaches the target range of 0.5 to 4.0 mIU/L per Endocrine Society guidelines, they no longer need tadalafil. Others still require a PDE5 inhibitor on top of optimized thyroid therapy.

Monitoring and Lab Work for the Combination

No additional lab monitoring is needed solely because a patient takes both drugs. Standard thyroid monitoring applies: TSH every 6 to 8 weeks after any levothyroxine dose change, then every 6 to 12 months once stable.

For tadalafil, no routine labs are mandated, but clinicians commonly check a basic metabolic panel and lipid panel to rule out cardiovascular risk factors driving the ED. Checking free and total testosterone is also appropriate, given the overlap between low testosterone, hypothyroidism, and ED in the same patient population.

One monitoring nuance: hyperthyroidism (whether from over-replacement or Graves disease) can amplify the cardiovascular effects of tadalafil. Excess thyroid hormone raises resting heart rate, increases cardiac output, and can lower blood pressure. Adding a vasodilator like tadalafil to this hemodynamic state could, in theory, exaggerate hypotension. The ATA recommends keeping TSH within range and avoiding over-replacement, especially in older adults with cardiovascular disease. This applies regardless of tadalafil use, but it is an extra reason to maintain accurate thyroid dosing.

Dose Timing: A Practical Protocol

Timing these two drugs correctly is simple but matters for levothyroxine efficacy. Here is a straightforward protocol:

Morning (fasting): Take levothyroxine with a full glass of water, at least 30 minutes before breakfast. No coffee, supplements, or other medications during this window. A 2008 study in Thyroid demonstrated that even coffee consumed within 30 minutes of levothyroxine reduces T4 absorption by up to 36%.

Any time (for on-demand tadalafil): Take tadalafil 10 mg or 20 mg approximately 1 to 2 hours before anticipated sexual activity. It can be taken with or without food. The tadalafil label notes that food does not affect the rate or extent of absorption.

Daily low-dose tadalafil (5 mg for ED or BPH): Take at the same time each day, ideally not within that 30 to 60-minute levothyroxine absorption window. Any other time of day is fine. There is no pharmacokinetic reason to separate the two by hours.

Patients who take calcium or iron supplements should separate those from levothyroxine by at least 4 hours. Tadalafil does not fall into this category and does not require a 4-hour separation.

When the Combination Requires Extra Caution

While the tadalafil-levothyroxine pair itself is low-risk, the patient's medication list rarely stops at two drugs. Common co-medications that do warrant attention:

Nitrates. Tadalafil is absolutely contraindicated with organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate). The combination can cause severe, potentially fatal hypotension. This applies regardless of thyroid status.

Alpha-blockers. Tadalafil 5 mg daily with tamsulosin 0.4 mg is considered acceptable, but higher tadalafil doses combined with non-selective alpha-blockers (doxazosin, terazosin) increase the risk of symptomatic hypotension. The tadalafil prescribing information advises that patients should be stable on alpha-blocker therapy before adding tadalafil.

Strong CYP3A4 inhibitors. Ketoconazole, itraconazole, ritonavir, and clarithromycin all raise tadalafil levels substantially. When a potent CYP3A4 inhibitor is added, the tadalafil dose should not exceed 10 mg every 72 hours for on-demand use, or 2.5 mg daily.

Warfarin. Levothyroxine increases the catabolism of vitamin K-dependent clotting factors. Starting or adjusting levothyroxine in a patient on warfarin requires more frequent INR monitoring per ATA guidance. Tadalafil does not affect warfarin pharmacokinetics, but the three-drug scenario needs careful INR tracking.

Hyperthyroidism, Over-Replacement, and Cardiovascular Risk

Over-replacement with levothyroxine, defined as a suppressed TSH below 0.1 mIU/L, increases the risk of atrial fibrillation, osteoporosis, and cardiovascular events. A 2015 meta-analysis in JAMA Internal Medicine found that subclinical hyperthyroidism was associated with a 68% increased risk of atrial fibrillation (HR 1.68 to 95% CI 1.16 to 2.43).

Tadalafil lowers systolic blood pressure by an average of 1.6 mmHg and diastolic by 0.8 mmHg at the 20 mg dose, per clinical trial data in the FDA label. This is modest and usually clinically insignificant. But in a patient who is iatrogenically hyperthyroid with a resting heart rate of 100+ bpm and already on an antihypertensive, adding tadalafil's vasodilatory effect could tip the hemodynamic balance. The fix is not to avoid tadalafil; it is to correct the levothyroxine dose.

Special Populations

Older adults (65+): No tadalafil dose adjustment is required by age alone, though the FDA label notes that area under the curve was 25% higher in healthy subjects aged 65 and older compared to younger men. Hypothyroidism prevalence rises with age, making co-prescription common. The TSH target in adults over 70 may be relaxed to 4.0 to 6.0 mIU/L per some expert recommendations, to avoid the cardiac risks of over-treatment.

Renal impairment: Tadalafil requires dose reduction in moderate-to-severe renal impairment (CrCl <30 mL/min): the maximum on-demand dose is 5 mg, once every 72 hours. Levothyroxine does not require renal dose adjustment, but hypothyroidism can reduce GFR, so correcting thyroid levels may improve renal function markers.

Hepatic impairment: Tadalafil exposure increases in patients with moderate hepatic impairment (Child-Pugh Class B); the maximum on-demand dose should not exceed 10 mg. Severe hepatic impairment (Child-Pugh Class C) has not been studied, and tadalafil is not recommended. Levothyroxine does not require hepatic dose adjustment.

Patient Counseling Points

Patients asking about this combination typically have two concerns: "Will these drugs cancel each other out?" and "Could the combination be dangerous?" The answer to both is no, under standard clinical conditions.

Key counseling messages for this combination: levothyroxine goes first in the morning, on an empty stomach. Tadalafil goes whenever you need it or at the same time each day if on the 5 mg regimen. Do not rearrange your thyroid medication timing to accommodate tadalafil. Report symptoms of over-replacement (palpitations, tremor, unintentional weight loss, heat intolerance) at any follow-up visit. If ED persists after TSH normalization, tadalafil at 5 mg daily or 10 to 20 mg on demand is safe to continue alongside levothyroxine.